Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Neurology
»
Parkinson
19. September 2026
Search
medline.ch
Parkinson
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2944
Articles 1 - 20 / 58876
Efficacy and Safety of Inhaled and Sublingual Apomorphine for On‑Demand Treatment of OFF Episodes in Parkinson Disease: A Systematic Review and Meta-Analysis With Exploratory Network Comparison.
Clin Neuropharmacol
Pitton Rissardo J, Vargas Rojas JL, Aristizabal Marin J, Fornari Caprara AL.
PMID: 42757652 [PubMed - as supplied by publisher]
Data-driven subtyping of Parkinson's disease using MRI: current insights, challenges, and future directions.
Front Aging Neurosci
Vijayakumari AA, Sakaie KE, Fernandez HH, Walter BL.
PMID: 42756554 [PubMed]
The role of metacognitive beliefs in impulse control disorders and addictive-like behaviors in Parkinson's disease: an exploratory study.
Front Psychiatry
Triscari S, Lenzo V, Sardella A, Caponnetto P, Galati A, Lupica P, Tasca D, Muratore S, Marano P, Caraci F, Quattropani MC.
PMID: 42756337 [PubMed]
Psychosocial determinants of exercise behavior in Parkinson's disease: a mini-review.
Front Public Health
Zhang G.
PMID: 42755561 [PubMed - indexed for MEDLINE]
Digital biomarkers derived from wearable sensors in neurorehabilitation: a scoping review.
Front Neurol
Shalabi KM, Mahmoud H, Pakkir Mohamed SH, Shaik SA.
PMID: 42755503 [PubMed - indexed for MEDLINE]
Metabolomic-microbiomic integrated analysis reveals the role of intermittent energy restriction in Parkinson's disease.
Neurodegener Dis Manag
Xu KS, You HJ, Yao RY, Hou BH, Li XY.
PMID: 42755373 [PubMed - as supplied by publisher]
Species-dependent activities of the PINK1-parkin axis.
Transl Neurodegener
Huang W, Chen K, Wen J, Zhang T, Li S, Li XJ, Yang W.
PMID: 42754914 [PubMed - indexed for MEDLINE]
High-frequency rTMS over supplementary motor or primary motor cortex on reach-to-grasp in Parkinson's disease: A randomised controlled trial.
Clin Neurophysiol
Thanakamchokchai J, Saengphatrachai W, Khacharoen S, Phuegsilp P, Srivanitchapoom P, Pitakpatapee Y, Pakaprot N, Fisher BE, Tretriluxana J.
PMID: 42754417 [PubMed - as supplied by publisher]
OnabotulinumtoxinA for Painful Foot Dystonia in Parkinson Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
Neurol Clin Pract
Mahjoub Y, Achen B, Alizadeh P, Abusrair A, Amorelli G, Cieslak A, Labelle N, Hammer T, Pantella C, Bruno V.
PMID: 42753227 [PubMed - indexed for MEDLINE]
Impact of Uncontrolled Motor Fluctuations in Parkinson's Disease: Real-World Insights from the PROSPECT Observational Study.
Adv Ther
Espay AJ, Defebvre L, de Fabregues O, Falconer D, Hasegawa K, Houghton D, Ledingham D, Lehn A, Mestre TA, Oeda T, Ory-Magne F, Sarna JR, Safarpour D, Colman S, Bergmann L, Kukreja P, Onuk K, Yan CH, Alonso PS.
PMID: 42752752 [PubMed - as supplied by publisher]
Knowledge structure and frontier trends of exercise interventions for Parkinson's disease: a bibliometric and visualized analysis.
Front Aging Neurosci
Yang J, Li H, Hu S, Xu Y, Zhang Y.
PMID: 42750941 [PubMed]
Deep Learning-Powered Plasmonic Platform for Decoding Dynamic Protein Aggregation Landscapes in Parkinson's Disease Progression.
Adv Mater
Zhou Y, Liu H, Yang X, Huang A, Li M, Dai Z, Liu S, Lu Y, Guo J, Liu S, Li C, Jiang C.
PMID: 42750405 [PubMed - as supplied by publisher]
Time-Varying Effective Network of Rehabilitation in Parkinson's Disease With Disease Laterality: A TMS-EEG Study.
CNS Neurosci Ther
Liu H, Jiang B, Yang X, Hu M, Zhu Q, Chen K, Xue C, Jin Z, Wang L, Funahashi S, Fang B, Pei G, Yan T.
PMID: 42750292 [PubMed - indexed for MEDLINE]
Psychiatric consultation outcomes in deep brain stimulation candidacy: clinical and psychosocial correlates from a retrospective cohort.
Neurol Sci
Koçyi, Ay .
PMID: 42747653 [PubMed - indexed for MEDLINE]
Repurposing Anticancer Drugs in Parkinson's Treatment: Molecular Pathways Driving Neuroprotection and Therapeutic Advancement.
Mol Neurobiol
Bedage PL, Dhanush Y, Chettri P, Shivakumar, Ahmed SS, Raghunathanaidu BD.
PMID: 42747624 [PubMed - indexed for MEDLINE]
Correction: Ultrasonography demonstrates vagus nerve atrophy in Parkinson's disease: a meta-analysis.
J Neurol
Sijben LCJ, van Kuijk SMJ, Jahanshahi A, Mess WH, Janssen MLF.
PMID: 42747571 [PubMed - in process]
Changes in peripheral inflammatory cytokines and clinical outcomes before and after deep brain stimulation in patients with Parkinson's disease with or without type 2 diabetes mellitus: an observational study.
Neurol Sci
Cui C, Zuo D, Shen D, Xiao Q, Li J.
PMID: 42747555 [PubMed - indexed for MEDLINE]
Moving Beyond the Hyperkinetic Hypothesis for Weight Gain After Deep Brain Stimulation in Parkinson Disease.
Neuromodulation
Eisinger RS, Hamimi SA, Lee JM, Gabriel ED, Halpern CH.
PMID: 42747368 [PubMed - as supplied by publisher]
A Pilot Study Evaluating the Effect of Artesunate on Glymphatic-Related Fluid Transport in Parkinson's Disease Mouse Models In Vivo and Ex Vivo.
CNS Neurosci Ther
Han WT, Lu WH, Xu H, Xie GH, Cao Y, Wu XY, Qiu F, Fu T.
PMID: 42747247 [PubMed - indexed for MEDLINE]
Awake or Asleep Subthalamic Deep Brain Stimulation for Parkinson's Disease: Further Research Is Needed.
Neurosurgery
Mikkelsen M, Sværke K, Fjeldhøj S, Rasmussen R, Bergdal O, Løkkegaard A.
PMID: 42747167 [PubMed - as supplied by publisher]
Articles 1 - 20 / 58876
Page 1 of 2944
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy